Donovan Joanne M.

Insider Reports History

Entity
Individual
Location
C/O Catabasis Pharmaceuticals, Inc., One Kendall Sq. Bldg. 1400 E Suite B14202, Cambridge, MA
Signature
John R. Moore Attorney-in-Fact for Donovan Joanne M.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Donovan Joanne M.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Edgewise Therapeutics, Inc. CMO Restricted Stock Units 23.1K $437K $18.91 Aug 12, 2024 Direct
Edgewise Therapeutics, Inc. CMO Common Stock 14.5K $411K $28.29 Sep 20, 2024 Direct
Edgewise Therapeutics, Inc. CMO Stock Option (Right to Buy) 139K Aug 12, 2024 Direct

Insider Reports Filed by Donovan Joanne M.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EWTX Edgewise Therapeutics, Inc. Sep 20, 2024 1 -$203K 4 Sep 24, 2024 CMO
EWTX Edgewise Therapeutics, Inc. Aug 12, 2024 2 $0 4 Aug 14, 2024 CMO
EWTX Edgewise Therapeutics, Inc. May 1, 2024 3 -$69.6K 4 May 3, 2024 CMO
EWTX Edgewise Therapeutics, Inc. Aug 17, 2023 1 $0 4 Aug 18, 2023 CMO
EWTX Edgewise Therapeutics, Inc. May 1, 2023 3 -$29K 4 May 3, 2023 CMO
EWTX Edgewise Therapeutics, Inc. Aug 8, 2022 1 $0 4 Aug 10, 2022 CMO
EWTX Edgewise Therapeutics, Inc. May 1, 2022 1 $0 4 May 3, 2022 CMO
EWTX Edgewise Therapeutics, Inc. Aug 17, 2021 1 $0 4 Aug 19, 2021 CMO